GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Philogen SpA (STU:78Q) » Definitions » Buildings And Improvements

Philogen SpA (STU:78Q) Buildings And Improvements : €18.88 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Philogen SpA Buildings And Improvements?

Philogen SpA's quarterly buildings and improvements declined from Dec. 2023 (€16.11 Mil) to Jun. 2024 (€16.01 Mil) but then increased from Jun. 2024 (€16.01 Mil) to Dec. 2024 (€18.88 Mil).

Philogen SpA's annual buildings and improvements increased from Dec. 2022 (€12.34 Mil) to Dec. 2023 (€16.11 Mil) and increased from Dec. 2023 (€16.11 Mil) to Dec. 2024 (€18.88 Mil).


Philogen SpA Buildings And Improvements Historical Data

The historical data trend for Philogen SpA's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Philogen SpA Buildings And Improvements Chart

Philogen SpA Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Buildings And Improvements
11.32 11.95 12.34 16.11 18.88

Philogen SpA Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Buildings And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.34 13.12 16.11 16.01 18.88

Philogen SpA Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction.  Broker and architect fees, permits, etc. can be covered within this category.  Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized.  Improvements are commonly recorded at acquisition cost.  Building improvement examples include roofing, remodeling, replacements, etc.


Philogen SpA Business Description

Industry
Traded in Other Exchanges
Address
Piazza La Lizza No. 7, Siena, ITA, 53100
Philogen SpA is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. The company's focus is predominantly related to oncology drug development, although the company has also brought products for the treatment of chronic inflammatory diseases to the clinic. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others. Geographically, the company operates in the European Union, Switzerland, and the United States of America.

Philogen SpA Headlines

No Headlines